PMC:7299399 / 2677-2924 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7299399","sourcedb":"PMC","sourceid":"7299399","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7299399","text":"y inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve the safety of viral vectors, including developing nonviral drug-delivery systems inspi","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":74,"end":78},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma74402"},{"subj":"T5","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T52287","span":{"begin":74,"end":78},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"}],"attributes":[{"subj":"T52287","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":220,"end":224},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T11","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"2_test","denotations":[{"id":"32519842-11642817-158445","span":{"begin":119,"end":120},"obj":"11642817"},{"id":"32519842-32341506-158446","span":{"begin":121,"end":122},"obj":"32341506"}],"attributes":[{"subj":"32519842-11642817-158445","pred":"source","obj":"2_test"},{"subj":"32519842-32341506-158446","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#ec93d6","default":true},{"id":"LitCovid-PD-CLO","color":"#93ece8"},{"id":"LitCovid-PD-CHEBI","color":"#eccd93"},{"id":"2_test","color":"#b393ec"}]}]}}